Testosterone could be included in a mediation analysis to assess the effect of vitamin D (exposure) on measures of prostate cancer progression (e.g., PSA or Gleason score as the outcome) through testosterone levels (mediator). The gene discussed is KLK3; the disease is prostate carcinoma.